18 F-FDOPA and MRI Findings in a Case of Multiple Sclerosis

Clin Nucl Med. 2022 Nov 1;47(11):974-976. doi: 10.1097/RLU.0000000000004335. Epub 2022 Jul 26.

Abstract

A 39-year-old woman with no significant medical history underwent a brain MRI because of headaches and dysarthria having lasted 3 weeks. A tumor lesion was suspected. PET imaging was decided. She underwent FDG and FDOPA PET, leading to the diagnosis of low-grade glioma. Three months later, a new imaging assessment was organized. It showed a decrease in the hypermetabolism of the lesion and the appearance of a second lesion questioning the diagnosis. Further assessment led to the conclusion of a multiple sclerosis. This case illustrates that FDOPA PET uptake should be interpreted with caution in patients with suspected primary brain tumors.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Brain Neoplasms* / pathology
  • Dihydroxyphenylalanine
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Magnetic Resonance Imaging / methods
  • Multiple Sclerosis* / complications
  • Multiple Sclerosis* / diagnostic imaging
  • Positron-Emission Tomography / methods
  • Radiopharmaceuticals
  • Sensitivity and Specificity

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Dihydroxyphenylalanine